Checking tissue during lumpectomy to reduce repeat surgeries
Part of Cancer, Skin clinical trials.
This trial tests a scanner that checks removed breast tissue during surgery to help surgeons remove all cancer the first time. If it works, fewer women may need a second operation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older.
- You have been diagnosed with invasive lobular carcinoma, ductal carcinoma in situ, or invasive carcinoma with ductal carcinoma in situ.
- You are planning to have breast-conserving surgery (lumpectomy) at the study hospital.
- You are not pregnant at the time of surgery.
- You have not received chemotherapy or hormone therapy for this breast cancer before surgery.
- You do not have an allergy to acriflavine (the dye used in the scanner).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new imaging tool that helps surgeons see if any cancer cells are left behind during a lumpectomy. It may reduce the need for a second surgery.
This study tests a new scanner that helps doctors see if all the breast cancer was removed during surgery, right there in the operating room. It may help reduce the chance of needing a second surgery.
This trial studies a special vacuum-assisted biopsy taken just before breast surgery to see how well pre-surgery (neoadjuvant) chemotherapy worked. It may help doctors understand whether patients truly had a complete or near-complete response on scans, which can guide next steps.
This study tests a new imaging tool that helps surgeons see cancer margins in real time during a lumpectomy, aiming to reduce the need for a second surgery. It is for women with early-stage breast cancer who are planning a lumpectomy.
This trial tests a new way to mark the area where breast cancer is removed during lumpectomy with oncoplastic reconstruction. The goal is to make follow-up radiation more precise and reduce the need for additional surgeries.
This study looks at a more personalized way to follow up after breast-conserving surgery (lumpectomy). It may use extra imaging scans to detect any return of cancer early, which could help you feel more secure and get treatment sooner if needed.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.